To The Moon

The market is sending several important signals beneath the surface. From the Magnificent Seven trading at their most attractive relative valuation in years, to NVIDIA reaching its cheapest multiple in over seven years, healthcare flashing a fresh Golden Cross, and single-stock volatility diverging sharply from the VIX, these developments suggest investors may be entering a very different market environment. Here are four charts worth watching. 1.Magnificent 7 Magnificent 7 Stocks are now trading at their cheapest valuation relative to the $S&P 500(.SPX)$ in more than a decade $Apple(AAPL)$ $Alphabet(GOOG)$ $Microsoft(MS

The market is much broader than most investors realize. Everyone is still talking about AI chips, HBM, and memory stocks. But if you look beneath the surface, leadership has quietly expanded across the market. This rally is no longer being driven by just a handful of AI names. Capital is rotating into multiple industries, and many of the strongest setups today are appearing outside the traditional AI trade. Here are the sectors worth watching. 🧬 Biotech & Healthcare Healthcare continues to attract fresh momentum as investors look beyond mega-cap tech. Names on my radar: $Erasca, Inc.(ERAS)$ $ImmunityBio, Inc.(IBRX)$ $AbCellera Biologics(ABCL)$

$ESS Tech Inc.(GWH)$ has spent 15 years developing battery technology that powers communities, businesses, and data centers without the safety risks and supply chain vulnerabilities of lithium-ion. Recognized by TIME as one of America's Top Green Tech Companies and by Fortune as one of the Most Innovative Companies in America for 2025 and 2026 ESS has built a proven track record in long-duration iron flow energy storage. Now, responding to surging demand from AI data centers and critical infrastructure operators, the company is making one of its most significant strategic moves to date. On June 23, 2026, ESS announced it is accelerating development of a sodium-ion battery energy storage system, focused on short- and medium-duration applications tha

As AI investment broadens beyond chips into enterprise software, cloud infrastructure, networking, and digital platforms, Citi has refreshed its top technology picks for the second half of 2026. The list spans AI infrastructure leaders, software innovators, semiconductor suppliers, and internet platforms positioned to benefit from the next phase of the AI investment cycle. Citi’s Top Tech Stocks for the Rest of 2026: $SanDisk Corp.(SNDK)$ $Advanced Micro Devices(AMD)$ $Applied Materials(AMAT)$ $Lumentum(LITE)$ $Datadog(DDOG)$ $Ciena(CIEN)$</

If the $S&P 500(.SPX)$ finishes the year with a 10%+ gain, it will be only the 2nd time in the history of the $SPX that it has had 4 straight years of double-digit returns. The other time was 1995-1999, just before the Dot Com Bubble burst 🤯 👀 Semiconductor Stocks $VanEck Semiconductor ETF(SMH)$ relative to M2 Money Supply 🚨 Now trading at double the peak of the Dot Com Bubble 🤯 👀 Semiconductor Stocks are very, very expensive 🤯 👀 Probably Fine? Energy Stocks just saw an outflow of $3.2 Billion over the last week, the largest in 2 years 🚨 🚨 Tech Stocks on track for their largest annual inflow in history 📈 📈

Something different. As an investor, I look for what I call "ambitious failures". CEOs moving quickly, taking big swings, and striking out every once in awhile is not necessarily a bad thing. Big thinkers and innovators play big. But as a shareholder betting on asymmetric returns, I WANT my leadership to play fast + play BIG. Couple examples of founders moving fast, playing big (and sometimes flopping): > bezos launched $Amazon.com(AMZN)$ 's fire phone, it flopped > $Meta Platforms, Inc.(META)$ zuckerberg went all in on metaverse, flopped > $Coinbase Global, Inc.(COIN)$ 's nft marketplace flopped > $GameStop(GME)$

Wall Street's forward earnings estimates continue to point to AI and semiconductor companies as the market's biggest growth engines. Here are the trillion-dollar giants and chip stocks expected to deliver the strongest EPS growth over the next 12 months. 1.FWD EPS Growth of $1T Club Stocks: - $Micron Technology(MU)$ +785% - $Samsung Electronics Co., Ltd.(SSNLF)$ +602% - $SK Hynix, Inc.(HXSCF)$ +420% - $NVIDIA(NVDA)$ +88% - $Broadcom(AVGO)$ +70% - $Eli Lilly(LLY)$ +50% - $Taiwan Semiconductor Manufact

While video games have historically been looked down on as something “only kids do”,that is no longer the case. Technological advances have made video games better, more engaging, and easier to play than ever before. Today, video games are popular with adults and kids alike and are a fast-growing $330B industry poised for rapid changes. With $6.6B in revenues, $Take-Two(TTWO)$ is the 10th largest video game company in the world! However, T2’s fortunes are set to change rapidly, with the release of the most anticipated entertainment product in human history. Grand Theft Auto 6 is set to be released on 19 November 2026. I firmly believe that GTA 6 will be completely transformative for the company, with sales and profits way above current analyst e

I have had a chance to think, and in my opinion, $IREN Ltd(IREN)$ spending $50M on Golden State Warriors sponsorship is moronic. IREN is a B2B infrastructure provider that largely focuses on serving the multi-hundred-billion-dollar hyperscaler AI demand. This is a waste of money that doesn't help them one bit with this objective. For an unprofitable company that had $234M in operating losses last quarter and that needs billions of dollars of capital to waste $50M a year on a B2C sponsorship is absolutely moronic. This is truly stupid, and the market justifiedly sold the stock. This is a very bad judgement call from the Roberts brothers. However, the company has strong AI assets, and on the grand scheme of things, $50M a year is not that much. Neve

Biotech is showing broad-based strength beyond the AI trade, with momentum building across oncology, neurology, immunology, genomics, rare diseases, drug discovery, and life science tools. This thematic watchlist highlights leading innovators positioned to benefit from the sector's accelerating pipeline and long-term growth trends. One of the strongest sectors outside of AI right now is Biotech. Oncology $Tango Therapeutics Inc.(TNGX)$ $Enliven Treateutics(ELVN)$ $Revolution Medicines, Inc.(RVMD)$ $Relay Therapeutics(RLAY)$ $CG Oncology Inc.(CGON)$